Navigation Links
Pluripotent ESC, To Serve As an Effective Therapy for Many Diseases

Silva and colleagues said they had accomplished the transformation of immature cells from men's testicles into powerful stem cells, which can later, differentiate into nerve, heart and bone cells. // Their work was presented at a meeting of stem cell researchers in Valencia, Spain. Gerd Hasenfuss of Georg-August-University in Goettingen, Germany and colleagues reported in the journal Nature that they have transformed mouse germ cells into stem cells.

The researchers, at Irvine, California-based PrimeGen Biotech, worked with immature cells (germ cells) found in testes and ovaries. Germ cells isolated from adult human testis can be therapeutically reprogramed to have the ability to differentiate into cells that can be used therapeutically for cell-based regenerative medicine. Silva said in a statement in the conference that stem cells are the body's master cells, and scientists are working to learn how to find and use them to replace tissue, to grow new organs, and to study diseases. Adult stem cells are found throughout the body, although they are difficult to identify.

Bone marrow stem cells are routinely used in transplants to treat cancer and other diseases. But they are already partly programmed and can serve as a source of only a limited range of related cells. Stem cells taken from the early foetuses (blastocyst) are flexible. These embryonic stem cells are pluripotent, and can serve as a source of any kind of cells or tissue in the body.

But use of embryonic stem cells is controversial as US federal law strictly limits the use of taxpayer funds for working with them. So researchers are seeking other sources of stem cells and Silva's team took cells from the testes of men aged 26 to 50 years old. They said that their main aim is to re-program them thereby they can be pluripotent. Then these cell lines can effectively be used to treat a number of diseases.


'"/>




Page: 1

Related medicine news :

1. Dummies Serve To Reduce Chances Of SIDS
2. Media Messages Can Serve To Reduce Smoking Indoors
3. Aspirin Serves To Reduce Cardiovascular Events
4. Preparing For The Worst Does Not Serve Any Purpose
5. Cancer Vaccine Could Serve As an Answer to Prevent Most of the Cancer
6. New Born Breast Fed Babies Will Serve As Growth Yardstick
7. Protein Expression to Serve as Marker for Head and Neck Cancer
8. From Excitement To Health - Coke To Serve All
9. Assam Recruits Doctors to Serve in Rural Areas
10. Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants
11. Kolkata Restaurants Serve Beckhams and Ronaldinhos on Plates
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and the impact ... the creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist and ... Walter. Walter and Jane have three adult children and a granddaughter. Walter ...
(Date:5/24/2017)... ... May 24, 2017 , ... Last month, representatives ... hospital employees, and town officials to celebrate the grand opening of the 87,000 ... Rendina as part of its ongoing relationship with RWJBarnabas Health, New Jersey’s largest ...
(Date:5/24/2017)... ... 2017 , ... Dr. Alan I. Benvenisty, MD is dual board certified in ... known for his distinguished expertise and experience in the diagnosis and treatment of vascular ... treating renovascular disease and aortic aneurysm . He is known for his minimally ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... management and interpretation, has received U.S. Food and Drug Administration (FDA) 510(k) ... web-based, scalable and secure cloud platform for medical image management. At the core ...
(Date:5/24/2017)... Cincinnati, OH (PRWEB) , ... May 24, 2017 , ... ... discreet and comfortable ClearCorrect orthodontics, with or without a referral. Dr. Kejriwal ... is why she offers convenient, clear braces in Cincinnati, OH. Patients no longer need ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/11/2017)... TORONTO , May 11, 2017  Thornhill ... ) has been awarded an $8,049,024 USD five-year, ... Defense through the Canadian Commercial Corporation (CCC) ( ... Field Anesthesia Systems to administer general anesthesia to ... environment.  "The US Marine Corps have ...
Breaking Medicine Technology: